Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era
Contributeurs/tricesBoffi El Amari, Emmanuelle Jane; Toutous Trellu, Laurence Marie; Gayet-Ageron, Angèle; Baumann, Michele; Cathomas, Gieri; Steffen, Ingrid; Erb, Peter; Mueller, Nicolas J.; Furrer, Hansjakob; Cavassini, Matthias; Vernazza, Pietro; Hirsch, Hans H.; Bernasconi, Enos; Hirschel, Bernard; Swiss HIV Cohort Study
Publié dansAIDS, vol. 22, no. 9, p. 1019-1028
Date de publication2008
Résumé
Mots-clés
- AIDS-Related Opportunistic Infections/drug therapy/epidemiology/mortality
- Adult
- Aged
- Antiretroviral Therapy, Highly Active
- CD4 Lymphocyte Count
- CD4-Positive T-Lymphocytes
- Disease Progression
- Female
- HIV Infections/drug therapy/epidemiology
- HIV-1
- Herpesvirus 8, Human/metabolism
- Humans
- Incidence
- Male
- Middle Aged
- Prevalence
- Prognosis
- Prospective Studies
- RNA, Viral/blood
- Retrospective Studies
- Risk Factors
- Sarcoma, Kaposi/drug therapy/epidemiology/mortality
- Switzerland/epidemiology
- Viral Load
Structure d'affiliation
Groupe de recherche
Citation (format ISO)
BOFFI EL AMARI, Emmanuelle Jane et al. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era. In: AIDS, 2008, vol. 22, n° 9, p. 1019–1028. doi: 10.1097/QAD.0b013e3282fc9c03
Fichiers principaux (1)
Article (Published version)
Identifiants
- PID : unige:1128
- DOI : 10.1097/QAD.0b013e3282fc9c03
- PMID : 18520345
ISSN du journal0269-9370